Showing 161 - 173 results of 173 for search '"Journal of Market Access & Health Policy"', query time: 0.11s Refine Results
  1. 161
    An algorithm to generate correlated input-parameters to be used in probabilistic sensitivity analyses

    An algorithm to generate correlated input-parameters to be used in probabilistic sensitivity analyses by Mohamed Neine, Desmond Curran

    Published 2021-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  2. 162
    Chinese guidelines related to novel coronavirus pneumonia

    Chinese guidelines related to novel coronavirus pneumonia by Tingting Qiu, Shuyao Liang, Monique Dabbous, Yitong Wang, Ru Han, Mondher Toumi

    Published 2020-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  3. 163
    From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses

    From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in compara... by Katia Thokagevistk, Clément François, Mélanie Brignone, Mondher Toumi

    Published 2019-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  4. 164
    Transformative potential of artificial intelligence in global health policy

    Transformative potential of artificial intelligence in global health policy by Ridwan Islam Sifat, Upali Bhattacharya

    Published 2023-12-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  5. 165
    Economic evaluation of biosimilars for reimbursement purposes – what, when, how?

    Economic evaluation of biosimilars for reimbursement purposes – what, when, how? by Evelien Moorkens, Hannah Broux, Isabelle Huys, Arnold G. Vulto, Steven Simoens

    Published 2020-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  6. 166
    Value added medicines: what value repurposed medicines might bring to society?

    Value added medicines: what value repurposed medicines might bring to society? by Mondher Toumi, Cécile Rémuzat

    Published 2017-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  7. 167
    Pharmaceutical Market Access: current state of affairs and key challenges – results of the Market Access Launch Excellence Inventory (MALEI)

    Pharmaceutical Market Access: current state of affairs and key challenges – results of the Market Access Launch Excellence Inventory (MALEI) by Marcus A. Koch

    Published 2015-12-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  8. 168
    Trends in US emergency department visits and subsequent hospital admission among patients with inflammatory bowel disease presenting with abdominal pain: a real-world study from a national emergency department sample database

    Trends in US emergency department visits and subsequent hospital admission among patients with inflammatory bowel disease presenting with abdominal pain: a real-world study from a... by Zhijie Ding, Aarti Patel, James Izanec, Christopher D. Pericone, Jennifer H. Lin, Christopher W. Baugh

    Published 2021-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  9. 169
    Government pharmaceutical pricing strategies in the Asia-Pacific region: an overview

    Government pharmaceutical pricing strategies in the Asia-Pacific region: an overview by Naina R. Verghese, Jon Barrenetxea, Yukti Bhargava, Sagun Agrawal, Eric Andrew Finkelstein

    Published 2019-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  10. 170
    Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany

    Economic evaluation of adverse events of dabrafenib plus trametinib versus nivolumab in patients with advanced BRAF-mutant cutaneous melanoma for adjuvant therapy in Germany by S Wahler, A Müller, C Koll, P Seyed-Abbaszadeh, JM Von Der Schulenburg

    Published 2021-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  11. 171
    Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United States

    Assessing the value of delandistrogene moxeparvovec (SRP-9001) gene therapy in patients with Duchenne muscular dystrophy in the United States by Alexa C. Klimchak, Lauren E. Sedita, Louise R. Rodino-Klapac, Jerry R. Mendell, Craig M. McDonald, Katherine L. Gooch, Daniel C. Malone

    Published 2023-12-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  12. 172
    Upgrading the SACT dataset and EBMT registry to enable outcomes-based reimbursement in oncology in England: a gap analysis and top-level cost estimate

    Upgrading the SACT dataset and EBMT registry to enable outcomes-based reimbursement in oncology in England: a gap analysis and top-level cost estimate by Jesper Jørgensen, Panos Kefalas

    Published 2019-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article
  13. 173
    Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma

    Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma by Xavier Armoiry, Hans-Martin Spath, Aileen Clarke, Martin Connock, Paul Sutcliffe, Claude Dussart

    Published 2019-01-01
    “…Journal of Market Access & Health Policy…”
    Get full text
    Article

Search Tools: